Kahn Partners
  • What we do
  • Deals
  • The Firm
  • News & Publications
  • Locations
  • Contact
Select Page

Acquisition of a U.S. IVD medical device company for a French publicly traded company (client).

Deals

Value: Over $100 million.

Skills

Posted on

November 8, 2022

← Sale of a European customer relationship management company (client) to one of the world leaders in technology consulting. Acquisition of CareDx’s Lab Products business by Eurobio Scientific (client), a French publicly traded IVD company. →

Recent Posts

  • Kahn Partners will attend the CES
  • New office in Washington D.C.
  • New office in Paris

Recent Comments

No comments to show.
Kahn Partners